Literature DB >> 9417883

Mode of the autocrine/paracrine mechanism of growth hormone action.

N Liu1, H C Mertani, G Norstedt, J Törnell, P E Lobie.   

Abstract

GH is synthesized at multiple extrapituitary sites suggestive of an autocrine/paracrine mechanism of action. We have investigated a possible autocrine/paracrine mechanism of GH action, compared the cellular response to exogenous versus endogenously produced GH, and determined the nature of the interaction between external stimuli and endogenously produced GH. BRL cells expressing the GH receptor were transiently transfected with expression plasmids containing either the hGH or the bGH gene and the response of the cell was measured by CAT reporter plasmids requiring either STATs 1 and 3 or STAT5 for their response. Transient transfection of the hGH gene resulted in hGH accumulation in the cell and secretion into the media. The functional response through STATs 1 and 3 and STAT5 obtained with endogenously produced hGH was comparable or greater in magnitude to that obtained with the maximal stimulatory dose of exogenous hGH. Similar results were obtained with an expression plasmid containing the bGH gene. Endogenously produced hGH interacted in an additive manner when combined with submaximal doses of both exogenous hGH and serum. Such results were also observed in a more physiologically relevant mammary carcinoma cell line (MCF-7). The nonreceptor-dimerizing hGH antagonist, hGH-G120R, used in cells expressing the homologous receptor extracellular domain was able to only partially inhibit the response of the cell to endogenously produced hGH, in contrast to full inhibition of exogenous hGH. We therefore conclude that GH can function in an autocrine/paracrine manner, additive in effect to external stimuli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417883     DOI: 10.1006/excr.1997.3789

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  The oncogenic potential of autocrine human growth hormone in breast cancer.

Authors:  Michael J Waters; Becky L Conway-Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

Review 2.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Growth hormone-dependent changes in the rat lung proteome during alveorization.

Authors:  J A Beyea; D M Olson; S Harvey
Journal:  Mol Cell Biochem       Date:  2008-11-05       Impact factor: 3.396

4.  Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-02-16

5.  Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes.

Authors:  Douglas A Weigent
Journal:  Cell Immunol       Date:  2013-04-11       Impact factor: 4.868

6.  Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Mervat S Mohamed; Shaymaa M M Yahya; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2012-05-05

Review 7.  The contribution of growth hormone to mammary neoplasia.

Authors:  Jo K Perry; Kumarasamypet M Mohankumar; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-07       Impact factor: 2.673

8.  The paracrine effect of exogenous growth hormone alleviates dysmorphogenesis caused by tbx5 deficiency in zebrafish (Danio rerio) embryos.

Authors:  Tzu-Chun Tsai; Jen-Kann Lu; Sie-Lin Choo; Shu-Yu Yeh; Ren-Bing Tang; Hsin-Yu Lee; Jen-Her Lu
Journal:  J Biomed Sci       Date:  2012-07-09       Impact factor: 8.410

9.  Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling.

Authors:  François Guesdon; Yahia Kaabi; Aiden H Riley; Ian R Wilkinson; Colin Gray; David C James; Peter J Artymiuk; Jon R Sayers; Richard J Ross
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

10.  P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy.

Authors:  Ahmed A Abd-Rabou; Emad F Eskander; Mervat S Mohamed; Shaymaa M M Yahya; Ashraf El Sherbini; Olfat G Shaker
Journal:  Genes Dis       Date:  2015-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.